Mylan claims win in Lantus patent battle, but legal war with Sanofi is far from over
Earlier this week, the FDA took aim at escalating insulin prices that have forced diabetics to ration out the drug as out-of-pocket costs soar …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
